MetaADEDB 2.0 @ LMMD
pazopanib
(MQHIQUBXFFAOMK-UHFFFAOYSA-N)
Structure
SMILES
CN(c1ccc2c(c1)nn(c2C)C)c1ccnc(n1)Nc1ccc(c(c1)S(=O)(=O)N)C.Cl
Molecular Formula:
C21H24ClN7O2S
Molecular Weight:
473.979
Log P:
5.7951
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
3
TPSA:
127.41
CAS Number(s):
635702-64-6
Synonym(s)
1.
pazopanib
2.
GW 780604
3.
GW 786034B
4.
GW-780604
5.
GW-786034B
6.
GW780604
7.
GW786034B
8.
Votrient
External Link(s)
MeSHC516667
PubChem Compound46864002
11525740
ChEBI71217
CHEMBLCHEMBL1201733
KEGGdr:D05380
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 1139
Canada Vigilance: 28
Canada Vigilance
US FAERS
2FatigueFAERS: 1067
Canada Vigilance: 27
Canada Vigilance
US FAERS
3Drug ineffectiveFAERS: 704
Canada Vigilance: 40
Canada Vigilance
US FAERS
4VomitingFAERS: 558
Canada Vigilance: 16
Canada Vigilance
US FAERS
5Malignant neoplasm progressionFAERS: 484
Canada Vigilance: 52
Canada Vigilance
US FAERS
6MalaiseFAERS: 473
Canada Vigilance: 21
Canada Vigilance
US FAERS
7Disease ProgressionFAERS: 444
Canada Vigilance: 2
Canada Vigilance
US FAERS
8Weight decreasedFAERS: 366
Canada Vigilance: 5
Canada Vigilance
US FAERS
9AstheniaFAERS: 331
Canada Vigilance: 9
Canada Vigilance
US FAERS
10HeadacheFAERS: 321
Canada Vigilance: 12
Canada Vigilance
US FAERS
11DysgeusiaFAERS: 273US FAERS
12PainFAERS: 245
Canada Vigilance: 5
Canada Vigilance
US FAERS
13Abdominal PainFAERS: 199
Canada Vigilance: 5
Canada Vigilance
US FAERS
14Abdominal discomfortFAERS: 177
Canada Vigilance: 3
Canada Vigilance
US FAERS
15DizzinessFAERS: 160
Canada Vigilance: 4
Canada Vigilance
US FAERS
16AlopeciaFAERS: 156
Canada Vigilance: 2
Canada Vigilance
US FAERS
17Drug dose omissionFAERS: 144US FAERS
18ArthralgiaFAERS: 133
Canada Vigilance: 6
Canada Vigilance
US FAERS
19Back PainFAERS: 133
Canada Vigilance: 5
Canada Vigilance
US FAERS
20ConstipationFAERS: 128
Canada Vigilance: 7
Canada Vigilance
US FAERS
21Hospice CareFAERS: 123US FAERS
22StomatitisFAERS: 122
Canada Vigilance: 5
Canada Vigilance
US FAERS
23DehydrationFAERS: 120
Canada Vigilance: 1
Canada Vigilance
US FAERS
24Product use in unapproved indicationFAERS: 112
Canada Vigilance: 7
Canada Vigilance
US FAERS
25Alanine Aminotransferase IncreasedFAERS: 101
Canada Vigilance: 4
Canada Vigilance
US FAERS
26DyspepsiaFAERS: 97
Canada Vigilance: 4
Canada Vigilance
US FAERS
27Renal Cell CarcinomaFAERS: 96US FAERS
28AgeusiaFAERS: 95
Canada Vigilance: 3
Canada Vigilance
US FAERS
29PneumoniaFAERS: 93
Canada Vigilance: 4
Canada Vigilance
US FAERS
30EpistaxisFAERS: 88
Canada Vigilance: 8
Canada Vigilance
US FAERS
31General physical health deteriorationFAERS: 88
Canada Vigilance: 1
Canada Vigilance
US FAERS
32Product use issueFAERS: 83US FAERS
33Chest PainFAERS: 82
Canada Vigilance: 6
Canada Vigilance
US FAERS
34MyalgiaFAERS: 82
Canada Vigilance: 2
Canada Vigilance
US FAERS
35Aspartate Aminotransferase IncreasedFAERS: 80
Canada Vigilance: 2
Canada Vigilance
US FAERS
36Feeling abnormalFAERS: 80
Canada Vigilance: 6
Canada Vigilance
US FAERS
37Cerebrovascular accidentFAERS: 79
Canada Vigilance: 3
Canada Vigilance
US FAERS
38Adverse eventFAERS: 75US FAERS
39PneumothoraxFAERS: 73
Canada Vigilance: 8
Canada Vigilance
US FAERS
40HypothyroidismFAERS: 72US FAERS
41jaundiceFAERS: 69
Canada Vigilance: 2
Canada Vigilance
US FAERS
42HepatotoxicityFAERS: 68
Canada Vigilance: 11
Canada Vigilance
US FAERS
43ErythemaFAERS: 66
Canada Vigilance: 2
Canada Vigilance
US FAERS
44Toxicity to various agentsFAERS: 66
Canada Vigilance: 2
Canada Vigilance
US FAERS
45ProteinuriaFAERS: 65US FAERS
46DysphoniaFAERS: 63
Canada Vigilance: 4
Canada Vigilance
US FAERS
47Therapy cessationFAERS: 63US FAERS
48PruritusFAERS: 62
Canada Vigilance: 1
Canada Vigilance
US FAERS
49Peripheral swellingFAERS: 61
Canada Vigilance: 5
Canada Vigilance
US FAERS
50NasopharyngitisFAERS: 60
Canada Vigilance: 6
Canada Vigilance
US FAERS
51Myocardial InfarctionFAERS: 59
Canada Vigilance: 5
Canada Vigilance
US FAERS
52Oral painFAERS: 57
Canada Vigilance: 1
Canada Vigilance
US FAERS
53InfectionFAERS: 54
Canada Vigilance: 2
Canada Vigilance
US FAERS
54No adverse eventFAERS: 53
Canada Vigilance: 1
Canada Vigilance
US FAERS
55Metastatic Renal Cell CarcinomaFAERS: 52
Canada Vigilance: 5
Canada Vigilance
US FAERS
56Visual ImpairmentFAERS: 52
Canada Vigilance: 2
Canada Vigilance
US FAERS
57Dry skinFAERS: 50
Canada Vigilance: 2
Canada Vigilance
US FAERS
58Urinary tract infectionFAERS: 50
Canada Vigilance: 4
Canada Vigilance
US FAERS
59Blood creatinine increasedFAERS: 48US FAERS
60FlatulenceFAERS: 48
Canada Vigilance: 2
Canada Vigilance
US FAERS
61Memory impairmentFAERS: 47
Canada Vigilance: 3
Canada Vigilance
US FAERS
62ThrombocytopeniaFAERS: 43
Canada Vigilance: 1
Canada Vigilance
US FAERS
63ThrombosisFAERS: 42
Canada Vigilance: 5
Canada Vigilance
US FAERS
64HypersensitivityFAERS: 41US FAERS
65ChromaturiaFAERS: 39
Canada Vigilance: 5
Canada Vigilance
US FAERS
66AnxietyFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
67Blood urine presentFAERS: 37
Canada Vigilance: 3
Canada Vigilance
US FAERS
68MetastasisFAERS: 37
Canada Vigilance: 2
Canada Vigilance
US FAERS
69Nephrotic SyndromeFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
70Oropharyngeal painFAERS: 37
Canada Vigilance: 2
Canada Vigilance
US FAERS
71Inappropriate schedule of drug administrationFAERS: 36US FAERS
72SepsisFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
73SomnolenceFAERS: 36
Canada Vigilance: 5
Canada Vigilance
US FAERS
74Burning sensationFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
75Ejection Fraction DecreasedFAERS: 35US FAERS
76HyperthyroidismFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
77AmnesiaFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
78PancreatitisFAERS: 33
Canada Vigilance: 3
Canada Vigilance
US FAERS
79Intestinal PerforationFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
80AscitesFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
81White blood cell count decreasedFAERS: 31US FAERS
82treatment failureFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
83Musculoskeletal PainFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
84RetchingFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
85Skin UlcerFAERS: 30US FAERS
86Blood alkaline phosphatase increasedFAERS: 29US FAERS
87Pulmonary EmbolismFAERS: 29
Canada Vigilance: 1
Canada Vigilance
US FAERS
88Bone painFAERS: 28US FAERS
89Respiratory FailureFAERS: 28US FAERS
90Chest discomfortFAERS: 27
Canada Vigilance: 3
Canada Vigilance
US FAERS
91Drug administration errorFAERS: 27US FAERS
92HypotensionFAERS: 27
Canada Vigilance: 5
Canada Vigilance
US FAERS
93InfluenzaFAERS: 27US FAERS
94ChillsFAERS: 25US FAERS
95Gamma-Glutamyltransferase IncreasedFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
96HepatitisFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
97Joint swellingFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
98PalpitationsFAERS: 25US FAERS
99Productive CoughFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
100Renal cancer metastaticFAERS: 25
Canada Vigilance: 10
Canada Vigilance
US FAERS
101UrticariaFAERS: 25US FAERS
102Blood thyroid stimulating hormone increasedFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
103Hypertensive crisisFAERS: 24US FAERS
104Intestinal ObstructionFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
105LethargyFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
106NeutropeniaFAERS: 23US FAERS
107TremorFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
108Posterior reversible encephalopathy syndromeFAERS: 21US FAERS
109Transaminases increasedFAERS: 20US FAERS
110SarcomaFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
111Gastric ulcerFAERS: 18US FAERS
112GastritisFAERS: 18US FAERS
113Neck PainFAERS: 18US FAERS
114Protein urine presentFAERS: 18US FAERS
115SyncopeFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
116Cardiac ArrestFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
117DisorientationFAERS: 17US FAERS
118Incorrect dose administeredFAERS: 17US FAERS
119Limb discomfortFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
120Musculoskeletal stiffnessFAERS: 17US FAERS
121AbasiaFAERS: 16US FAERS
122Acute kidney injuryFAERS: 16US FAERS
123HyperkeratosisFAERS: 16US FAERS
124Therapeutic response unexpectedFAERS: 16US FAERS
125Vitreous floatersFAERS: 16US FAERS
126Blood glucose increasedFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Concomitant disease aggravatedFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
128DeafnessFAERS: 15US FAERS
129Deep Vein ThrombosisFAERS: 15US FAERS
130DiscomfortFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
131PallorFAERS: 15US FAERS
132TachycardiaFAERS: 15US FAERS
133Tumour haemorrhageFAERS: 15US FAERS
134Atrial FibrillationFAERS: 14US FAERS
135Disseminated Intravascular CoagulationFAERS: 14US FAERS
136DysuriaFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
137HypersomniaFAERS: 14US FAERS
138LeukopeniaFAERS: 14US FAERS
139Metastatic NeoplasmFAERS: 14US FAERS
140Pericardial effusionFAERS: 14US FAERS
141PeritonitisFAERS: 14US FAERS
142Terminal stateFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
143TinnitusFAERS: 14US FAERS
144ArthritisFAERS: 13US FAERS
145BlindnessFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
146Blood count abnormalFAERS: 13US FAERS
147Rash erythematousFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
148SwellingFAERS: 13US FAERS
149Therapy non-responderFAERS: 13
Canada Vigilance: 2
Canada Vigilance
US FAERS
150Throat irritationFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
151VertigoFAERS: 13US FAERS
152furuncleFAERS: 13US FAERS
153Angina PectorisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
154AsphyxiaFAERS: 12US FAERS
155Blood glucose decreasedFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
156Blood lactate dehydrogenase increasedFAERS: 12US FAERS
157BronchitisFAERS: 12US FAERS
158Cancer PainFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
159DiverticulitisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
160Emergency care examinationFAERS: 12US FAERS
161Feeling ColdFAERS: 12US FAERS
162Gastrointestinal perforationFAERS: 12US FAERS
163Hip surgeryFAERS: 12US FAERS
164Increased tendency to bruiseFAERS: 12US FAERS
165Osteonecrosis of JawFAERS: 12US FAERS
166AcneFAERS: 11US FAERS
167Amylase increasedFAERS: 11US FAERS
168AphoniaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
169Blood sodium decreasedFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
170BradycardiaFAERS: 11US FAERS
171CellulitisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
172CholestasisFAERS: 11US FAERS
173ColitisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
174InflammationFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
175NephrolithiasisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
176PancytopeniaFAERS: 11US FAERS
177Pulmonary congestionFAERS: 11US FAERS
178Respiratory arrestFAERS: 11US FAERS
179SinusitisFAERS: 11US FAERS
180Wrong technique in product usage processFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
181Decreased immune responsivenessFAERS: 10US FAERS
182Diabetes MellitusFAERS: 10US FAERS
183Eye painFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
184GlossitisFAERS: 10US FAERS
185HypogeusiaFAERS: 10US FAERS
186HypophagiaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
187Mental status changesFAERS: 10US FAERS
188Musculoskeletal chest painFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
189Musculoskeletal discomfortFAERS: 10US FAERS
190Retinal DetachmentFAERS: 10US FAERS
191Skin irritationFAERS: 10US FAERS
192Therapy changeFAERS: 10US FAERS
193ToothacheFAERS: 10US FAERS
194Unevaluable eventFAERS: 10US FAERS
195AgitationFAERS: 9US FAERS
196Blood potassium increasedFAERS: 9US FAERS
197CataractFAERS: 9US FAERS
198CholecystitisFAERS: 9US FAERS
199CystitisFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
200DementiaFAERS: 9US FAERS
201Duodenal UlcerFAERS: 9US FAERS
202DysarthriaFAERS: 9US FAERS
203Inappropriate schedule of product administrationFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
204Lower respiratory tract infectionFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
205Mental impairmentFAERS: 9US FAERS
206NeuralgiaFAERS: 9US FAERS
207Night sweatsFAERS: 9US FAERS
208Nonspecific reactionFAERS: 9US FAERS
209Pulmonary thrombosisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
210Septic ShockFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
211Skin lesionFAERS: 9US FAERS
212SunburnFAERS: 9US FAERS
213Tooth ExtractionFAERS: 9US FAERS
214Blood cholesterol increasedFAERS: 8US FAERS
215Blood potassium decreasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
216CachexiaFAERS: 8US FAERS
217Cell DeathFAERS: 8US FAERS
218ChokingFAERS: 8US FAERS
219Depressed Level of ConsciousnessFAERS: 8US FAERS
220Ear discomfortFAERS: 8US FAERS
221Epigastric discomfortFAERS: 8US FAERS
222FlushingFAERS: 8US FAERS
223Full blood count decreasedFAERS: 8US FAERS
224HemiplegiaFAERS: 8US FAERS
225HerniaFAERS: 8US FAERS
226Large intestine perforationFAERS: 8US FAERS
227LaryngitisFAERS: 8US FAERS
228NervousnessFAERS: 8US FAERS
229Neutrophil count decreasedFAERS: 8US FAERS
230OverdoseFAERS: 8US FAERS
231Pain of skinFAERS: 8US FAERS
232PneumonitisFAERS: 8US FAERS
233Skin toxicityFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
234Activities of daily living impairedFAERS: 7US FAERS
235Apparent deathFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
236AsthmaFAERS: 7US FAERS
237CardiotoxicityFAERS: 7US FAERS
238CholelithiasisFAERS: 7US FAERS
239CytopeniaFAERS: 7US FAERS
240Depressed moodFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
241DermatitisFAERS: 7US FAERS
242EnterocolitisFAERS: 7US FAERS
243EructationFAERS: 7US FAERS
244FractureFAERS: 7US FAERS
245HyperacusisFAERS: 7US FAERS
246HyperchlorhydriaFAERS: 7US FAERS
247Limb operationFAERS: 7US FAERS
248LymphadenopathyFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
249Metastases to adrenalsFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
250MonoplegiaFAERS: 7US FAERS
251NoduleFAERS: 7US FAERS
252Pancreatic carcinomaFAERS: 7US FAERS
253Performance status decreasedFAERS: 7US FAERS
254Quality of life decreasedFAERS: 7US FAERS
255RegurgitationFAERS: 7US FAERS
256Rehabilitation therapyFAERS: 7US FAERS
257RhabdomyolysisFAERS: 7US FAERS
258StressFAERS: 7US FAERS
259AphasiaFAERS: 6US FAERS
260AppendicitisFAERS: 6US FAERS
261Cataract operationFAERS: 6US FAERS
262DysenteryFAERS: 6US FAERS
263Enterocutaneous FistulaFAERS: 6US FAERS
264Flank PainFAERS: 6US FAERS
265Gait inabilityFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
266Head discomfortFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
267Hepatic necrosisFAERS: 6US FAERS
268Lipase increasedFAERS: 6US FAERS
269Metastases to stomachFAERS: 6US FAERS
270NecrosisFAERS: 6US FAERS
271PetechiaeFAERS: 6US FAERS
272PurpuraFAERS: 6US FAERS
273Pyoderma GangrenosumFAERS: 6US FAERS
274Renal cancer recurrentFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
275Respiratory distressFAERS: 6US FAERS
276Tongue blisteringFAERS: 6US FAERS
277Tooth LossFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
278UlcerFAERS: 6US FAERS
279WheezingFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
280leiomyosarcomaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
281Abdominal tendernessFAERS: 5US FAERS
282AbscessFAERS: 5US FAERS
283Accidental overdoseFAERS: 5US FAERS
284Altered state of consciousnessFAERS: 5US FAERS
285AngerFAERS: 5US FAERS
286Anorectal discomfortFAERS: 5US FAERS
287AtelectasisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
288Blood creatine increasedFAERS: 5US FAERS
289Blood triglycerides increasedFAERS: 5US FAERS
290Blood urea increasedFAERS: 5US FAERS
291Bone lesionFAERS: 5US FAERS
292Central nervous system lesionFAERS: 5US FAERS
293Cerebral InfarctionFAERS: 5US FAERS
294Clostridium difficile infectionFAERS: 5US FAERS
295Device related infectionFAERS: 5US FAERS
296Disease complicationFAERS: 5US FAERS
297DysgraphiaFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
298Electrocardiogram abnormalFAERS: 5US FAERS
299Emotional disorderFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
300Enzyme level increasedFAERS: 5US FAERS
301Erythema MultiformeFAERS: 5US FAERS
302Food AllergyFAERS: 5US FAERS
303Gastrointestinal PainFAERS: 5US FAERS
304HepatomegalyFAERS: 5US FAERS
305HydronephrosisFAERS: 5US FAERS
306HypokinesiaFAERS: 5US FAERS
307InfarctionFAERS: 5US FAERS
308Intentional product use issueFAERS: 5US FAERS
309Living in residential institutionFAERS: 5US FAERS
310Lymphangiosis carcinomatosaFAERS: 5US FAERS
311MalabsorptionFAERS: 5US FAERS
312NephrectomyFAERS: 5US FAERS
313Noninfective gingivitisFAERS: 5US FAERS
314ObstructionFAERS: 5US FAERS
315OnychoclasisFAERS: 5US FAERS
316PneumoperitoneumFAERS: 5US FAERS
317Poor quality sleepFAERS: 5US FAERS
318Product quality issueFAERS: 5US FAERS
319Skin ErosionFAERS: 5US FAERS
320Skin reactionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
321SluggishnessFAERS: 5US FAERS
322Urinary RetentionFAERS: 5US FAERS
323cancer surgeryFAERS: 5US FAERS
324synovial sarcomaFAERS: 5US FAERS
325Abdominal rigidityFAERS: 4US FAERS
326Atrioventricular BlockFAERS: 4US FAERS
327BedriddenFAERS: 4US FAERS
328Blood electrolytes increasedFAERS: 4US FAERS
329Blood pressure inadequately controlledFAERS: 4US FAERS
330Cerebral disorderFAERS: 4US FAERS
331CystFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
332Drug prescribing errorFAERS: 4US FAERS
333Electrolyte imbalanceFAERS: 4US FAERS
334Extremity necrosisFAERS: 4US FAERS
335Gastrointestinal sounds abnormalFAERS: 4US FAERS
336Gingival RecessionFAERS: 4US FAERS
337GoutFAERS: 4US FAERS
338HemiparesisFAERS: 4US FAERS
339HungerFAERS: 4US FAERS
340HypertransaminasaemiaFAERS: 4US FAERS
341IncoherentFAERS: 4US FAERS
342Joint injuryFAERS: 4US FAERS
343Joint stiffnessFAERS: 4US FAERS
344Lung AbscessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
345LymphomaFAERS: 4US FAERS
346MalnutritionFAERS: 4US FAERS
347Medication ErrorFAERS: 4US FAERS
348Metastases to thoraxFAERS: 4US FAERS
349Middle insomniaFAERS: 4US FAERS
350Ocular icterusFAERS: 4US FAERS
351Oral infectionFAERS: 4US FAERS
352Oral mucosal exfoliationFAERS: 4US FAERS
353ParaplegiaFAERS: 4US FAERS
354Penile erythemaFAERS: 4US FAERS
355PharyngitisFAERS: 4US FAERS
356Product physical issueFAERS: 4US FAERS
357Pulmonary painFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
358Renal painFAERS: 4US FAERS
359Rheumatoid ArthritisFAERS: 4US FAERS
360ScabFAERS: 4US FAERS
361Squamous cell carcinomaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
362Sudden deathFAERS: 4US FAERS
363Synovial sarcoma metastaticFAERS: 4US FAERS
364Tongue eruptionFAERS: 4US FAERS
365Tooth InfectionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
366Urinary IncontinenceFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
367VasculitisFAERS: 4US FAERS
368Ventricular hypokinesiaFAERS: 4US FAERS
369nervous system disorderFAERS: 4US FAERS
370Acute myocardial infarctionFAERS: 3US FAERS
371AlbinismFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
372AlbuminuriaFAERS: 3US FAERS
373Anal FissureFAERS: 3US FAERS
374Anal abscessFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
375AphagiaFAERS: 3US FAERS
376Arteriovenous fistulaFAERS: 3US FAERS
377Aspartate aminotransferase decreasedFAERS: 3US FAERS
378Bile duct stent insertionFAERS: 3US FAERS
379Bilirubin conjugated increasedFAERS: 3US FAERS
380Blood albumin decreasedFAERS: 3US FAERS
381Blood blisterFAERS: 3US FAERS
382Blood creatine phosphokinase increasedFAERS: 3US FAERS
383Blood creatinine abnormalFAERS: 3US FAERS
384Blood iron increasedFAERS: 3US FAERS
385Blood magnesium decreasedFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
386Blood pressure fluctuationFAERS: 3US FAERS
387BronchopneumoniaFAERS: 3US FAERS
388Buccal mucosal rougheningFAERS: 3US FAERS
389Cardiac dysfunctionFAERS: 3US FAERS
390Cardiac ventricular thrombosisFAERS: 3US FAERS
391CardiomegalyFAERS: 3US FAERS
392CatarrhFAERS: 3US FAERS
393CheilitisFAERS: 3US FAERS
394Concomitant disease progressionFAERS: 3US FAERS
395Coronary Artery DiseaseFAERS: 3US FAERS
396Crystal deposit intestineFAERS: 3US FAERS
397Dental cariesFAERS: 3US FAERS
398DiplopiaFAERS: 3US FAERS
399Drug ineffective for unapproved indicationFAERS: 3US FAERS
400Drug level decreasedFAERS: 3US FAERS
401Drug resistanceFAERS: 3US FAERS
402Emergency CareFAERS: 3US FAERS
403EncephalitisFAERS: 3US FAERS
404Endodontic procedureFAERS: 3US FAERS
405Failure to ThriveFAERS: 3US FAERS
406Feeling of body temperature changeFAERS: 3US FAERS
407Full blood count increasedFAERS: 3US FAERS
408GastroenteritisFAERS: 3US FAERS
409Gastrointestinal infectionFAERS: 3US FAERS
410Genital rashFAERS: 3US FAERS
411GingivitisFAERS: 3US FAERS
412HaematotoxicityFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
413High frequency ablationFAERS: 3US FAERS
414Hilar lymphadenopathyFAERS: 3US FAERS
415HydrocephalusFAERS: 3US FAERS
416IleusFAERS: 3US FAERS
417ImmobileFAERS: 3US FAERS
418IncontinenceFAERS: 3US FAERS
419Initial insomniaFAERS: 3US FAERS
420Intracranial massFAERS: 3US FAERS
421Irritable Bowel SyndromeFAERS: 3US FAERS
422LabyrinthitisFAERS: 3US FAERS
423Limb injuryFAERS: 3US FAERS
424Lip swellingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
425Lung consolidationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
426Lymphocyte count decreasedFAERS: 3US FAERS
427LymphopeniaFAERS: 3US FAERS
428Medical device implantationFAERS: 3US FAERS
429Medication residue presentFAERS: 3US FAERS
430Multiple allergiesFAERS: 3US FAERS
431Muscle tightnessFAERS: 3US FAERS
432MyopiaFAERS: 3US FAERS
433MyositisFAERS: 3US FAERS
434Oral fungal infectionFAERS: 3US FAERS
435Oral mucosal erythemaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
436Oropharyngeal blisteringFAERS: 3US FAERS
437OsteosarcomaFAERS: 3US FAERS
438Palliative CareFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
439Paranasal sinus discomfortFAERS: 3US FAERS
440Perivascular dermatitisFAERS: 3US FAERS
441PiloerectionFAERS: 3US FAERS
442Post procedural complicationFAERS: 3US FAERS
443Prescribed underdoseFAERS: 3US FAERS
444Procedural complicationFAERS: 3US FAERS
445Product dose omissionFAERS: 3US FAERS
446Protein total decreasedFAERS: 3US FAERS
447Psychiatric symptomFAERS: 3US FAERS
448RhabdomyosarcomaFAERS: 3US FAERS
449SarcopeniaFAERS: 3US FAERS
450Secretion dischargeFAERS: 3US FAERS
451Sensitive skinFAERS: 3US FAERS
452Status EpilepticusFAERS: 3US FAERS
453Stevens-Johnson SyndromeFAERS: 3US FAERS
454Subcutaneous EmphysemaFAERS: 3US FAERS
455Supraventricular tachycardiaFAERS: 3US FAERS
456Therapeutic procedureFAERS: 3US FAERS
457ThirstFAERS: 3US FAERS
458Thoracic cavity drainageFAERS: 3US FAERS
459Thyroid hormones decreasedFAERS: 3US FAERS
460Unresponsive to stimuliFAERS: 3US FAERS
461Upper-airway cough syndromeFAERS: 3US FAERS
462Uterine CancerFAERS: 3US FAERS
463Vena cava filter insertionFAERS: 3US FAERS
464White blood cell count abnormalFAERS: 3US FAERS
465colonoscopyFAERS: 3US FAERS
466Abdominal AbscessFAERS: 2US FAERS
467Abdominal InfectionFAERS: 2US FAERS
468Abdominal massFAERS: 2US FAERS
469Acute Coronary SyndromeFAERS: 2US FAERS
470Alcohol poisoningFAERS: 2US FAERS
471Allergic sinusitisFAERS: 2US FAERS
472Anal FistulaFAERS: 2US FAERS
473AneurysmFAERS: 2US FAERS
474AngioedemaFAERS: 2US FAERS
475Anorexia NervosaFAERS: 2US FAERS
476AnosmiaFAERS: 2US FAERS
477AnuriaFAERS: 2US FAERS
478Aortic AneurysmFAERS: 2US FAERS
479Arterial thrombosisFAERS: 2US FAERS
480ArthropathyFAERS: 2US FAERS
481Atrial FlutterFAERS: 2US FAERS
482Bacterial TranslocationFAERS: 2US FAERS
483BalanoposthitisFAERS: 2US FAERS
484Benign Prostatic HyperplasiaFAERS: 2US FAERS
485Bladder painFAERS: 2US FAERS
486Blood lactate dehydrogenase abnormalFAERS: 2US FAERS
487Blood lactate dehydrogenase decreasedFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
488Blood potassium abnormalFAERS: 2US FAERS
489Blood thyroid stimulating hormone decreasedFAERS: 2US FAERS
490Bowel movement irregularityFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
491Brain natriuretic peptide increasedFAERS: 2US FAERS
492Breast tendernessFAERS: 2US FAERS
493BronchiectasisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
494Bronchopulmonary AspergillosisFAERS: 2US FAERS
495BronchospasmFAERS: 2US FAERS
496Burning feet syndromeFAERS: 2US FAERS
497CalcinosisFAERS: 2US FAERS
498Cardiac HypertrophyFAERS: 2US FAERS
499Cardiac TamponadeFAERS: 2US FAERS
500Cerebral atrophyFAERS: 2US FAERS
501Cerebral ventricular ruptureFAERS: 2US FAERS
502ChemotherapyFAERS: 2US FAERS
503CholangitisFAERS: 2US FAERS
504Chondrosarcoma metastaticFAERS: 2US FAERS
505Colonic fistulaFAERS: 2US FAERS
506Compression fractureFAERS: 2US FAERS
507ConvalescentFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
508CryingFAERS: 2US FAERS
509DeliriumFAERS: 2US FAERS
510Device breakageFAERS: 2US FAERS
511Diabetic FootFAERS: 2US FAERS
512Diastolic dysfunctionFAERS: 2US FAERS
513Drug ToleranceFAERS: 2US FAERS
514Drug dispensing errorFAERS: 2US FAERS
515Drug effect incompleteFAERS: 2US FAERS
516Duodenal perforationFAERS: 2US FAERS
517DyscheziaFAERS: 2US FAERS
518DyschromatopsiaFAERS: 2US FAERS
519DysphemiaFAERS: 2US FAERS
520EczemaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
521Electrocardiogram changeFAERS: 2US FAERS
522EmbolismFAERS: 2US FAERS
523Endometrial Stromal SarcomaFAERS: 2US FAERS
524Enterocolitis bacterialFAERS: 2US FAERS
525EosinophiliaFAERS: 2US FAERS
526EpilepsyFAERS: 2US FAERS
527Escherichia infectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
528Extra dose administeredFAERS: 2US FAERS
529Extra-osseous Ewing's sarcomaFAERS: 2US FAERS
530Fluid overloadFAERS: 2US FAERS
531Gastrointestinal stoma complicationFAERS: 2US FAERS
532Gastrointestinal toxicityFAERS: 2US FAERS
533Gastrointestinal ulcerFAERS: 2US FAERS
534Hepatic EncephalopathyFAERS: 2US FAERS
535Hepatic enzyme decreasedFAERS: 2US FAERS
536HypermetabolismFAERS: 2US FAERS
537HypotrichosisFAERS: 2US FAERS
538ImmunosuppressionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
539Increased upper airway secretionFAERS: 2US FAERS
540Infected neoplasmFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
541Intermittent ClaudicationFAERS: 2US FAERS
542Intervertebral Disc DegenerationFAERS: 2US FAERS
543Intestinal resectionFAERS: 2US FAERS
544Jugular vein distensionFAERS: 2US FAERS
545LacerationFAERS: 2US FAERS
546Left atrial dilatationFAERS: 2US FAERS
547LeukoencephalopathyFAERS: 2US FAERS
548Lung cystFAERS: 2US FAERS
549Macular degenerationFAERS: 2US FAERS
550Malignant Fibrous HistiocytomaFAERS: 2US FAERS
551Malignant ascitesFAERS: 2US FAERS
552Malignant neoplasm of spinal cordFAERS: 2US FAERS
553Maternal exposure timing unspecifiedFAERS: 2US FAERS
554MeningiomaFAERS: 2US FAERS
555MeningitisFAERS: 2US FAERS
556Metastases to muscleFAERS: 2US FAERS
557MetrorrhagiaFAERS: 2US FAERS
558Muscle abscessFAERS: 2US FAERS
559Nasal discomfortFAERS: 2US FAERS
560Nephritic syndromeFAERS: 2US FAERS
561Non-cardiac chest painFAERS: 2US FAERS
562OsteomyelitisFAERS: 2US FAERS
563Pathological fractureFAERS: 2US FAERS
564Peripheral artery thrombosisFAERS: 2US FAERS
565Peripheral embolismFAERS: 2US FAERS
566Platelet count abnormalFAERS: 2US FAERS
567PleurisyFAERS: 2US FAERS
568PneumocephalusFAERS: 2US FAERS
569Polymyalgia RheumaticaFAERS: 2US FAERS
570Poor peripheral circulationFAERS: 2US FAERS
571Post procedural dischargeFAERS: 2US FAERS
572Post procedural swellingFAERS: 2US FAERS
573Potentiating drug interactionFAERS: 2US FAERS
574Product taste abnormalFAERS: 2US FAERS
575Protein total increasedFAERS: 2US FAERS
576PsoriasisFAERS: 2US FAERS
577Pulmonary FibrosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
578Pulmonary toxicityFAERS: 2US FAERS
579Rectal abscessFAERS: 2US FAERS
580Renal abscessFAERS: 2US FAERS
581Renal massFAERS: 2US FAERS
582Respiratory ParalysisFAERS: 2US FAERS
583RestlessnessFAERS: 2US FAERS
584RhinalgiaFAERS: 2US FAERS
585Scan abnormalFAERS: 2US FAERS
586Sinus headacheFAERS: 2US FAERS
587Skin PapillomaFAERS: 2US FAERS
588Skin necrosisFAERS: 2US FAERS
589Splenic InfarctionFAERS: 2US FAERS
590Squamous cell carcinoma of lungFAERS: 2US FAERS
591Subcutaneous AbscessFAERS: 2US FAERS
592Temperature intoleranceFAERS: 2US FAERS
593TensionFAERS: 2US FAERS
594Therapy partial responderFAERS: 2US FAERS
595Thermal burnFAERS: 2US FAERS
596Thirst decreasedFAERS: 2US FAERS
597Thoracic vertebral fractureFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
598Thyroid hormones increasedFAERS: 2US FAERS
599ThyroiditisFAERS: 2US FAERS
600Tongue discomfortFAERS: 2US FAERS
601Tongue exfoliationFAERS: 2US FAERS
602Troponin T increasedFAERS: 2US FAERS
603Typhoid FeverFAERS: 2US FAERS
604UnderweightFAERS: 2US FAERS
605Urine output increasedFAERS: 2US FAERS
606VIIth nerve paralysisFAERS: 2US FAERS
607Vaginal DischargeFAERS: 2US FAERS
608Ventricular hypertrophyFAERS: 2US FAERS
609Viral upper respiratory tract infectionFAERS: 2US FAERS
610Vitreous DetachmentFAERS: 2US FAERS
611Vulvovaginal burning sensationFAERS: 2US FAERS
612Wound dehiscenceFAERS: 2US FAERS
613XanthomaFAERS: 2US FAERS
614diagnostic procedureFAERS: 2US FAERS
615intensive careFAERS: 2US FAERS
616liposarcomaFAERS: 2US FAERS
617Abdominal adhesionsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
618Abdominal cavity drainageFAERS: 1US FAERS
619Abdominal sepsisFAERS: 1US FAERS
620Abdominal symptomFAERS: 1US FAERS
621Abdominal wound dehiscenceFAERS: 1US FAERS
622Accidental exposure to productFAERS: 1US FAERS
623Achromotrichia acquiredFAERS: 1US FAERS
624AcidosisFAERS: 1US FAERS
625Acute respiratory failureFAERS: 1US FAERS
626AdrenalectomyFAERS: 1US FAERS
627Amaurosis FugaxFAERS: 1US FAERS
628Ammonia abnormalFAERS: 1US FAERS
629AmyloidosisFAERS: 1US FAERS
630Amyotrophic Lateral SclerosisFAERS: 1US FAERS
631Anal fistula infectionFAERS: 1US FAERS
632Anal inflammationFAERS: 1US FAERS
633Anastomotic complicationFAERS: 1US FAERS
634Antinuclear antibody increasedFAERS: 1US FAERS
635Arterial insufficiencyFAERS: 1US FAERS
636AsterixisFAERS: 1US FAERS
637AstrocytomaFAERS: 1US FAERS
638Atrial thrombosisFAERS: 1US FAERS
639Atypical pneumoniaFAERS: 1US FAERS
640BabesiosisFAERS: 1US FAERS
641Back disorderFAERS: 1US FAERS
642Base excess decreasedFAERS: 1US FAERS
643Bile output abnormalFAERS: 1US FAERS
644Biopsy liver abnormalFAERS: 1US FAERS
645BiopsyFAERS: 1US FAERS
646Bladder tamponadeFAERS: 1US FAERS
647BlastomycosisFAERS: 1US FAERS
648BlepharospasmFAERS: 1US FAERS
649Blood bilirubin abnormalFAERS: 1US FAERS
650Blood chloride decreasedFAERS: 1US FAERS
651Blood creatine abnormalFAERS: 1US FAERS
652Blood creatine phosphokinase MBFAERS: 1US FAERS
653Blood electrolytes abnormalFAERS: 1US FAERS
654Blood erythropoietin increasedFAERS: 1US FAERS
655Blood glucose abnormalFAERS: 1US FAERS
656Blood glucose fluctuationFAERS: 1US FAERS
657Blood phosphorus decreasedFAERS: 1US FAERS
658Blood sodium abnormalFAERS: 1US FAERS
659Blood testosterone decreasedFAERS: 1US FAERS
660Blood zinc decreasedFAERS: 1US FAERS
661BradyphreniaFAERS: 1US FAERS
662Brain ContusionFAERS: 1US FAERS
663Brain DeathFAERS: 1US FAERS
664Breast angiosarcoma metastaticFAERS: 1US FAERS
665Breast cancer recurrentFAERS: 1US FAERS
666BursitisFAERS: 1US FAERS
667Cardiac discomfortFAERS: 1US FAERS
668Cardiac function test abnormalFAERS: 1US FAERS
669Cardiac perforationFAERS: 1US FAERS
670Cardiac ventricular disorderFAERS: 1US FAERS
671Cardiovascular insufficiencyFAERS: 1US FAERS
672Carotid artery occlusionFAERS: 1US FAERS
673Central venous catheter removalFAERS: 1US FAERS
674Cerebellar infarctionFAERS: 1US FAERS
675Cerebral ThrombosisFAERS: 1US FAERS
676Chemical injuryFAERS: 1US FAERS
677Chest wall necrosisFAERS: 1US FAERS
678Cholecystitis infectiveFAERS: 1US FAERS
679CholelithotomyFAERS: 1US FAERS
680Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
681ColectomyFAERS: 1US FAERS
682Colon cancer recurrentFAERS: 1US FAERS
683Completed SuicideFAERS: 1US FAERS
684Complex partial seizuresFAERS: 1US FAERS
685ConjunctivitisFAERS: 1US FAERS
686Coronary artery insufficiencyFAERS: 1US FAERS
687CraniotomyFAERS: 1US FAERS
688Creatine urine increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
689Creatinine renal clearance decreasedFAERS: 1US FAERS
690Crystal nephropathyFAERS: 1US FAERS
691Cyst drainageFAERS: 1US FAERS
692CystopexyFAERS: 1US FAERS
693Cytogenetic analysis abnormalFAERS: 1US FAERS
694Cytokine Release SyndromeFAERS: 1US FAERS
695Cytology abnormalFAERS: 1US FAERS
696Dermatitis acneiformFAERS: 1US FAERS
697Device occlusionFAERS: 1US FAERS
698Diabetes mellitus inadequate controlFAERS: 1US FAERS
699Dialysis device insertionFAERS: 1US FAERS
700Diaphragmatic HerniaFAERS: 1US FAERS
701Diaphragmatic abnormal relaxationFAERS: 1US FAERS
702Diastolic hypertensionFAERS: 1US FAERS
703Diet refusalFAERS: 1US FAERS
704DiplegiaFAERS: 1US FAERS
705DisabilityFAERS: 1US FAERS
706Diverticular perforationFAERS: 1US FAERS
707DiverticulumFAERS: 1US FAERS
708DroolingFAERS: 1US FAERS
709Drug effect variableFAERS: 1US FAERS
710DyscalculiaFAERS: 1US FAERS
711DysplasiaFAERS: 1US FAERS
712Eating disorder symptomFAERS: 1US FAERS
713EcchymosisFAERS: 1US FAERS
714Electrocardiogram repolarisation abnormalityFAERS: 1US FAERS
715Embolic strokeFAERS: 1US FAERS
716Emphysematous cystitisFAERS: 1US FAERS
717EndocarditisFAERS: 1US FAERS
718Endotracheal intubation complicationFAERS: 1US FAERS
719EnteritisFAERS: 1US FAERS
720Eosinophil percentage increasedFAERS: 1US FAERS
721Erosive DuodenitisFAERS: 1US FAERS
722ErysipelasFAERS: 1US FAERS
723Erythema InduratumFAERS: 1US FAERS
724Erythema NodosumFAERS: 1US FAERS
725Escherichia urinary tract infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
726Euphoric moodFAERS: 1US FAERS
727Exfoliative rashFAERS: 1US FAERS
728Exposed bone in jawFAERS: 1US FAERS
729Exposure via partnerFAERS: 1US FAERS
730Eye InfectionFAERS: 1US FAERS
731Eye irritationFAERS: 1US FAERS
732Eyelid painFAERS: 1US FAERS
733Facial paralysisFAERS: 1US FAERS
734Fat necrosisFAERS: 1US FAERS
735Febrile NeutropeniaFAERS: 1US FAERS
736Fistula dischargeFAERS: 1US FAERS
737Foaming at mouthFAERS: 1US FAERS
738Food PoisoningFAERS: 1US FAERS
739Food aversionFAERS: 1US FAERS
740Gamma-glutamyltransferase abnormalFAERS: 1US FAERS
741GangreneFAERS: 1US FAERS
742Gastric infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
743Gastrointestinal anastomotic complicationFAERS: 1US FAERS
744Gastrointestinal carcinomaFAERS: 1US FAERS
745Gastrointestinal hypomotilityFAERS: 1US FAERS
746Gastrointestinal inflammationFAERS: 1US FAERS
747Gastrointestinal motility disorderFAERS: 1US FAERS
748General physical condition abnormalFAERS: 1US FAERS
749Genital abscessFAERS: 1US FAERS
750Genital painFAERS: 1US FAERS
751Genital swellingFAERS: 1US FAERS
752Gingival AtrophyFAERS: 1US FAERS
753Granulocyte count decreasedFAERS: 1US FAERS
754Grip strength decreasedFAERS: 1US FAERS
755Guillain-Barre SyndromeFAERS: 1US FAERS
756HaematinuriaFAERS: 1US FAERS
757Hallucinations, mixedFAERS: 1US FAERS
758Hearing aid userFAERS: 1US FAERS
759Helicobacter test positiveFAERS: 1US FAERS
760Hepatitis BFAERS: 1US FAERS
761Hepatitis CFAERS: 1US FAERS
762Hernia painFAERS: 1US FAERS
763HypercreatinaemiaFAERS: 1US FAERS
764HyperleukocytosisFAERS: 1US FAERS
765HyperlipasaemiaFAERS: 1US FAERS
766HyperpyrexiaFAERS: 1US FAERS
767Hypertensive EncephalopathyFAERS: 1US FAERS
768Hypertensive emergencyFAERS: 1US FAERS
769Hypothalamo-pituitary disorderFAERS: 1US FAERS
770HypoventilationFAERS: 1US FAERS
771HypoxiaFAERS: 1US FAERS
772Impaired driving abilityFAERS: 1US FAERS
773Impaired gastric emptyingFAERS: 1US FAERS
774Impaired self-careFAERS: 1US FAERS
775Impaired work abilityFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
776Implantable defibrillator insertionFAERS: 1US FAERS
777Incarcerated inguinal herniaFAERS: 1US FAERS
778Incorrect route of product administrationFAERS: 1US FAERS
779IndurationFAERS: 1US FAERS
780Infrequent bowel movementsFAERS: 1US FAERS
781Inhibitory drug interactionFAERS: 1US FAERS
782Injection site painFAERS: 1US FAERS
783Insurance issueFAERS: 1US FAERS
784Intellectual DisabilityFAERS: 1US FAERS
785Intentional dose omissionFAERS: 1US FAERS
786Intentional product misuseFAERS: 1US FAERS
787Intestinal FistulaFAERS: 1US FAERS
788Intestinal metaplasiaFAERS: 1US FAERS
789Intestinal metastasisFAERS: 1US FAERS
790Intra-abdominal fluid collectionFAERS: 1US FAERS
791Intra-abdominal pressure increasedFAERS: 1US FAERS
792Jejunal ulcerFAERS: 1US FAERS
793Joint Range of Motion DecreasedFAERS: 1US FAERS
794Kidney perforationFAERS: 1US FAERS
795Labile blood pressureFAERS: 1US FAERS
796Lactose IntoleranceFAERS: 1US FAERS
797Laser TherapyFAERS: 1US FAERS
798LeukocytosisFAERS: 1US FAERS
799Ligament painFAERS: 1US FAERS
800Lip and/or oral cavity cancerFAERS: 1US FAERS
801LipomatosisFAERS: 1US FAERS
802Liposarcoma recurrentFAERS: 1US FAERS
803Liver function test decreasedFAERS: 1US FAERS
804Low density lipoprotein increasedFAERS: 1US FAERS
805Lower respiratory tract congestionFAERS: 1US FAERS
806Lyme DiseaseFAERS: 1US FAERS
807Lymphatic system neoplasmFAERS: 1US FAERS
808Lymphocyte percentage decreasedFAERS: 1US FAERS
809Lymphocytic infiltrationFAERS: 1US FAERS
810Malignant HypertensionFAERS: 1US FAERS
811Mallory-Weiss SyndromeFAERS: 1US FAERS
812Mastication disorderFAERS: 1US FAERS
813Mechanical ventilationFAERS: 1US FAERS
814Medial Tibial Stress SyndromeFAERS: 1US FAERS
815Mediastinal CystFAERS: 1US FAERS
816Mediastinal massFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
817Medical device discomfortFAERS: 1US FAERS
818Mesenteric PanniculitisFAERS: 1US FAERS
819Metabolic acidosisFAERS: 1US FAERS
820Metastases to abdominal wallFAERS: 1US FAERS
821Metastases to pelvisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
822MiliariaFAERS: 1US FAERS
823Mole excisionFAERS: 1US FAERS
824Monocyte count increasedFAERS: 1US FAERS
825MultimorbidityFAERS: 1US FAERS
826Muscle strainFAERS: 1US FAERS
827Myocardial necrosis marker increasedFAERS: 1US FAERS
828Nail InfectionFAERS: 1US FAERS
829Negative thoughtsFAERS: 1US FAERS
830Neuromuscular painFAERS: 1US FAERS
831Neutrophil count abnormalFAERS: 1US FAERS
832NocturiaFAERS: 1US FAERS
833Ocular HypertensionFAERS: 1US FAERS
834Ocular discomfortFAERS: 1US FAERS
835OligodipsiaFAERS: 1US FAERS
836OliguriaFAERS: 1US FAERS
837Oncologic complicationFAERS: 1US FAERS
838OnychalgiaFAERS: 1US FAERS
839Open woundFAERS: 1US FAERS
840Optic NeuropathyFAERS: 1US FAERS
841Oral candidiasisFAERS: 1US FAERS
842Oral pruritusFAERS: 1US FAERS
843OsteitisFAERS: 1US FAERS
844OsteochondrosisFAERS: 1US FAERS
845OsteoporosisFAERS: 1US FAERS
846Osteosarcoma recurrentFAERS: 1US FAERS
847Otitis MediaFAERS: 1US FAERS
848OtotoxicityFAERS: 1US FAERS
849Oxygen supplementationFAERS: 1US FAERS
850PCO2 decreasedFAERS: 1US FAERS
851Pain managementFAERS: 1US FAERS
852Palmar erythemaFAERS: 1US FAERS
853PancreatectomyFAERS: 1US FAERS
854Pancreatic CystFAERS: 1US FAERS
855Pancreatic InsufficiencyFAERS: 1US FAERS
856Pancreatic NeoplasmFAERS: 1US FAERS
857Pancreatic PseudocystFAERS: 1US FAERS
858Pancreatic cyst ruptureFAERS: 1US FAERS
859Pancreatic enzymes increasedFAERS: 1US FAERS
860Pancreatic leakFAERS: 1US FAERS
861PanniculitisFAERS: 1US FAERS
862ParakeratosisFAERS: 1US FAERS
863Paranasal sinus hypersecretionFAERS: 1US FAERS
864Parasite blood test positiveFAERS: 1US FAERS
865ParesisFAERS: 1US FAERS
866ParophthalmiaFAERS: 1US FAERS
867Patient-device incompatibilityFAERS: 1US FAERS
868Pelvic cystFAERS: 1US FAERS
869Pelvic fluid collectionFAERS: 1US FAERS
870Pelvic massFAERS: 1US FAERS
871PeriarthritisFAERS: 1US FAERS
872Perihepatic discomfortFAERS: 1US FAERS
873PeriodontitisFAERS: 1US FAERS
874Peripheral arterial occlusive diseaseFAERS: 1US FAERS
875Peripheral motor neuropathyFAERS: 1US FAERS
876Peritoneal lesionFAERS: 1US FAERS
877Peritonsillar AbscessFAERS: 1US FAERS
878PhimosisFAERS: 1US FAERS
879PhotophobiaFAERS: 1US FAERS
880Plantar erythemaFAERS: 1US FAERS
881PlasmacytomaFAERS: 1US FAERS
882Pleuritic painFAERS: 1US FAERS
883PleurodesisFAERS: 1US FAERS
884PoisoningFAERS: 1US FAERS
885PolyneuropathyFAERS: 1US FAERS
886PolyuriaFAERS: 1US FAERS
887Portal Vein ThrombosisFAERS: 1US FAERS
888Positron emission tomogram abnormalFAERS: 1US FAERS
889Positron emission tomogram normalFAERS: 1US FAERS
890Post procedural discomfortFAERS: 1US FAERS
891Post procedural infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
892Postrenal failureFAERS: 1US FAERS
893Prescribed overdoseFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
894PresyncopeFAERS: 1US FAERS
895Product communication issueFAERS: 1US FAERS
896Product dispensing errorFAERS: 1US FAERS
897Product distribution issueFAERS: 1US FAERS
898Product packaging quantity issueFAERS: 1US FAERS
899Product prescribing errorFAERS: 1US FAERS
900Prostatic specific antigen decreasedFAERS: 1US FAERS
901PrurigoFAERS: 1US FAERS
902Pulmonary HypertensionFAERS: 1US FAERS
903Pulmonary InfarctionFAERS: 1US FAERS
904Pulmonary function test decreasedFAERS: 1US FAERS
905Pulmonary necrosisFAERS: 1US FAERS
906PyodermaFAERS: 1US FAERS
907Radiation mucositisFAERS: 1US FAERS
908Radiation necrosisFAERS: 1US FAERS
909Radiation proctitisFAERS: 1US FAERS
910RalesFAERS: 1US FAERS
911Rebound effectFAERS: 1US FAERS
912Recall phenomenonFAERS: 1US FAERS
913Red blood cell schistocytes presentFAERS: 1US FAERS
914Refractory cancerFAERS: 1US FAERS
915Renal artery stent placementFAERS: 1US FAERS
916Renal cystFAERS: 1US FAERS
917Respiratory DepressionFAERS: 1US FAERS
918Respiratory TherapyFAERS: 1US FAERS
919Respiratory tract congestionFAERS: 1US FAERS
920Restrictive pulmonary diseaseFAERS: 1US FAERS
921Retinal Artery OcclusionFAERS: 1US FAERS
922Retinal Vascular DisorderFAERS: 1US FAERS
923Retinal Vein OcclusionFAERS: 1US FAERS
924Retinal exudatesFAERS: 1US FAERS
925Retroperitoneal fibrosisFAERS: 1US FAERS
926Right ventricular failureFAERS: 1US FAERS
927Saliva alteredFAERS: 1US FAERS
928SarcoidosisFAERS: 1US FAERS
929SciaticaFAERS: 1US FAERS
930Scrotal InfectionFAERS: 1US FAERS
931Secondary hypothyroidismFAERS: 1US FAERS
932Senile dementiaFAERS: 1US FAERS
933Sensation of blood flowFAERS: 1US FAERS
934Septic embolusFAERS: 1US FAERS
935SerositisFAERS: 1US FAERS
936Shunt occlusionFAERS: 1US FAERS
937Single functional kidneyFAERS: 1US FAERS
938Sinoatrial BlockFAERS: 1US FAERS
939Sinus ArrhythmiaFAERS: 1US FAERS
940Skeletal injuryFAERS: 1US FAERS
941Skin hypertrophyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
942Skin lacerationFAERS: 1US FAERS
943Skin tightnessFAERS: 1US FAERS
944Small intestine carcinomaFAERS: 1US FAERS
945SomnambulismFAERS: 1US FAERS
946Spinal column injuryFAERS: 1US FAERS
947Spinal cord herniationFAERS: 1US FAERS
948Spinal cord infectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
949Splenic vein thrombosisFAERS: 1US FAERS
950SplinterFAERS: 1US FAERS
951StenosisFAERS: 1US FAERS
952Stent malfunctionFAERS: 1US FAERS
953StubbornnessFAERS: 1US FAERS
954SubileusFAERS: 1US FAERS
955Suicide attemptFAERS: 1US FAERS
956Superinfection bacterialFAERS: 1US FAERS
957Swollen tear ductFAERS: 1US FAERS
958Synovial CystFAERS: 1US FAERS
959Systolic dysfunctionFAERS: 1US FAERS
960TachyarrhythmiaFAERS: 1US FAERS
961Teeth brittleFAERS: 1US FAERS
962Therapy regimen changedFAERS: 1US FAERS
963Thrombotic strokeFAERS: 1US FAERS
964Thyroid NeoplasmFAERS: 1US FAERS
965Thyroid cancer metastaticFAERS: 1US FAERS
966ThyroidectomyFAERS: 1US FAERS
967Toe operationFAERS: 1US FAERS
968Toxic Epidermal NecrolysisFAERS: 1US FAERS
969Transitional cell carcinoma urethraFAERS: 1US FAERS
970Troponin TFAERS: 1US FAERS
971Troponin increasedFAERS: 1US FAERS
972Trousseau's syndromeFAERS: 1US FAERS
973Urea renal clearance decreasedFAERS: 1US FAERS
974Urethral ObstructionFAERS: 1US FAERS
975UrethritisFAERS: 1US FAERS
976Urinary tract inflammationFAERS: 1US FAERS
977Vaginal FistulaFAERS: 1US FAERS
978Vagus Nerve DisorderFAERS: 1US FAERS
979Vascular occlusionFAERS: 1US FAERS
980Vascular purpuraFAERS: 1US FAERS
981Venous thrombosis limbFAERS: 1US FAERS
982Ventricular arrhythmiaFAERS: 1US FAERS
983VertebroplastyFAERS: 1US FAERS
984Vocal Cord ParalysisFAERS: 1US FAERS
985Vulvovaginal drynessFAERS: 1US FAERS
986Vulvovaginal painFAERS: 1US FAERS
987Vulvovaginal pruritusFAERS: 1US FAERS
988Waist circumference increasedFAERS: 1US FAERS
989Weaning failureFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
990Wheelchair userFAERS: 1US FAERS
991Wound closureFAERS: 1US FAERS
992Wound decompositionFAERS: 1US FAERS
993Wrong scheduleFAERS: 1US FAERS
994Wrong technique in drug usage processFAERS: 1US FAERS
995XanthopsiaFAERS: 1US FAERS
996XerosisFAERS: 1US FAERS
997angiogramFAERS: 1US FAERS
998carbuncleFAERS: 1US FAERS
999fibromaFAERS: 1US FAERS
1000skin abrasionFAERS: 1US FAERS
1001Tongue erythemaCanada Vigilance: 1Canada Vigilance
1002Total lung capacity abnormalCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120236

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.